Brief: Valbiotis Completes Phase I/II Clinical Study Recruitment For VAL-070

Valbiotis SA

27/02/2018 16:36

Feb 27 (Reuters) - VALBIOTIS SAS  ALVAL.PA : 
    * VALBIOTIS COMPLETES PHASE I/II CLINICAL STUDY RECRUITMENT 
FOR 
VAL-070, A PRODUCT TO REDUCE A CARDIOVASCULAR RISK FACTOR 
    * CLINICAL SAFETY AND EFFICACY RESULTS ARE EXPECTED FOR 
MID-2018 
 
Source text for Eikon:  ID:nBw9d6r7La  
Further company coverage:  ALVAL.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))